NEW YORK (GenomeWeb News) – Proteome Sciences and Millipore jointly announced today that they will collaborate on the development of multiplex immunoassays for Alzheimer's disease research.
Under terms of the deal, Millipore will develop the immunoassays on the Luminex platform to measure Proteome Sciences' Alzheimer's disease biomarkers. Billerica, Mass.-based Millipore will have exclusive rights to develop and sell Luminex bead-based panels for Alzheimer's research as well as other cognitive function disorders.